Promotions & Moves

Patheon Appoints President

Lagarde brings 20 years of financial ops experience

Michel Lagarde has been appointed to the newly created role of president of Patheon, effective immediately. Mr. Lagarde will lead global corporate and cross-enterprise operations and report to CEO, James Mullen.
 
Mr. Lagarde joins the company from JLL Partners, a private equity firm with businesses across healthcare, financial services, building products and aerospace/defense. He has worked with several of JLL’s portfolio companies in the healthcare and pharma services sectors as managing director, including Patheon. He served as a member of Patheon’s board of directors since 2011.
 
He has worked closely with Mr. Mullen and members of Patheon’s executive committee for the past five years, during which, Patheon completed and integrated five strategic acquisitions.
 
“The creation of the president role is a demonstration of our efforts to expand our leadership capabilities and position the company for future growth,” said Mr. Mullen. “As a member of Patheon’s board and operating partner at JLL, Michel has developed a keen sense of what it will take to compete in the marketplace going forward and continue to drive the consolidation of our industry. Michel and I have partnered to build Patheon over the past five years. As we transition to a public company we can continue this partnership in his new role.  Michel’s strong financial acumen, industry knowledge and global business experience will be an asset to the company.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters